Esperion Therapeutics, Inc. (ESPR) Shares Sold by UBS Asset Management Americas Inc

The Massachusetts-based Rhumbline Advisers has invested 0% in Esperion Therapeutics Inc (NASDAQ:ESPR). Savings Bank Of Montreal Can stated it has 0% of its portfolio in Esperion Therapeutics Inc (NASDAQ:ESPR). The stock of Esperion Therapeutics Inc (NASDAQ:ESPR) has "Outperform" rating given on Friday, November 6 by RBC Capital Markets. RBC Capital Markets has "Outperform" rating and $40 target. Barclays Capital downgraded Esperion Therapeutics Inc (NASDAQ:ESPR) on Wednesday, June 29 to "Equal-Weight" rating. They now have a United States dollars 72 price target on the stock. The firm has "Neutral" rating by Credit Suisse given on Monday, March 20. The rating was upgraded by Citigroup to "Buy" on Tuesday, February 28. Sandy Spring Fincl Bank stated it has 0.01% in Owens & Minor, Inc. The shares have accelerated in recent weeks, with their price up about 13.01% in the past three months. These shares are worth $33,328,000 and were traded at $41.66 each. Home Depot Inc Com now has $193.00 billion valuation. Macquarie Gp has 1.31M shares for 0.08% of their portfolio. The Q4 2017 consensus earnings estimates for the company have stabilized at US$-1.79 per share. (NYSE:OMI) has declined 11.64% since October 19, 2016 and is downtrending. It has outperformed by 1.95% the S&P500.

Since May 2, 2017, it had 0 buys, and 6 selling transactions for $3.00 million activity.

ESPR) was down -1.45% (-$0.77) to $52.21 and showed a volume of 0.3 mln shares. Alliancebernstein Ltd Partnership invested in 0% or 30,070 shares.

Shares of Esperion Therapeutics, Inc. Hewett Wayne M. had bought 350 shares worth $54,989 on Wednesday, May 17. OMI's SI was 8.63 million shares in October as released by FINRA.

Among 29 analysts covering The Home Depot Inc.

Among 6 analysts covering Owens & Minor (NYSE:OMI), 0 have Buy rating, 2 Sell and 4 Hold. Therefore 60% are positive.

A number of equities analysts recently issued reports on the company. On Wednesday, April 6 the stock rating was maintained by Goldman Sachs with "Neutral". RBC Capital Markets maintained the stock with "Sector Perform" rating in Thursday, February 23 report. The rating was maintained by Credit Suisse with "Outperform" on Wednesday, November 18. The rating was upgraded by Needham on Monday, August 10 to "Buy". On Monday, November 7 the stock rating was downgraded by Bank of America to "Underperform". Barclays Public Ltd Company owns 11,116 shares for 0% of their portfolio.

According to Zacks brokerage recommendations, Esperion Therapeutics, Inc. The firm has "Neutral" rating given on Monday, October 31 by Piper Jaffray. Jefferies maintained the shares of LAD in report on Friday, September 8 with "Buy" rating. The stock of Home Depot Inc (NYSE:HD) earned "Neutral" rating by Atlantic Securities on Thursday, May 11.

Investors sentiment decreased to 1.22 in Q2 2017. Its down 0.52, from 1.74 in 2017Q1. It is positive, as 38 investors sold HD shares while 632 reduced holdings. Dimensional Fund Advisors LP raised its stake in Esperion Therapeutics by 174.7% during the 1st quarter. Emory University invested in 1.91% or 46,766 shares. Institutional investors own 83.30% of the company's stock. Murphy Cap Mngmt has invested 2.18% of its portfolio in Home Depot Inc (NYSE:HD). Esperion Therapeutics had 44 analyst reports since July 28, 2015 according to SRatingsIntel. Regentatlantic Capital Limited Liability has 36,089 shares. Meditor Group Ltd acquired a new position in shares of Esperion Therapeutics in the 2nd quarter worth $26,194,000. State Of Wisconsin Investment Board has invested 0% in Esperion Therapeutics Inc (NASDAQ:ESPR). Guggenheim Cap Ltd Liability Corp invested in 51,667 shares. 3,774 are owned by First Natl Bank. Bridgeway Capital Mgmt Inc holds 0.01% or 92,960 shares. Cleararc Cap invested 1.32% in Home Depot Inc (NYSE:HD). Prelude Capital Lc holds 0% or 200 shares in its portfolio.

Analysts expect Esperion Therapeutics Inc (NASDAQ:ESPR) to report $-1.78 EPS on November, 2.They anticipate $1.01 EPS change or 131.17% from last quarter's $-0.77 EPS. The 5 months wedge indicates low risk for the $1.34B company.

Esperion Therapeutics (NASDAQ:ESPR) last announced its quarterly earnings results on Tuesday, August 8th. It now has negative earnings. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this


19 October 2017
EA closes Visceral Games
In a move that surprised a lot of people, Electronic Arts shut down their in-house video game development studio, Visceral Games . There's been a shift in the game industry lately toward these types of games and EA is likely looking to cash in on the model.

19 October 2017
Jon Jones on the receiving end of brutal rant from Dana White
Former UFC Light Heavyweight Champion Jon Jones is awaiting punishment from USADA for a failed drug test in line with UFC 214 . Since the positive test, Jones has been stripped of the title and Cormier was named the champion.

19 October 2017
Jio 'Diwali Dhamaka' at just Rs 149 with double data
Another change in all its plans is that the post FUP speed in unlimited data plans has been reduced from 128Kbps to 64Kbps. Jio will offer the Rs 509 plan which offers 2 GB high-speed data per day to users for a validity period of 49 days.

19 October 2017
Chinese online small consumer credit provider Qudian debuts on NYSE
Profit jumped nearly eight times to US$144 million in the six months ended June, while revenue rose near five-fold to US$270 million.

19 October 2017
Destiny 2 preloads are now live
All of the footage included in the new trailer were captured in-game from the PC version of the title. I have no idea what it could be aside from the full game preload, but I'll let you know how it goes.

19 October 2017
Jeremy Lin Leaves Court In Tears After Suffering Knee Injury
Myles Turner had 21 points and 14 rebounds , and Thaddeus Young added 17 points and 11 rebounds . Lin scored 18 points, and the Nets' starting shooting guard D'Angelo Russell had 30.

19 October 2017
Becton Dickinson and Co (BDX) Holdings Lifted by Virtu KCG Holdings LLC
The Firm provides gas and fluid handling and fabrication technology services and products to clients around the world. Barclays Capital maintained Becton Dickinson and Co (NYSE: BDX ) on Thursday, August 10 with "Equal-Weight" rating.

19 October 2017
Paul Scholes: Manchester United star Nemanja Matic is an awkward player
Gerrard has now heaped praise on Matic, describing him as one of the most hard players that he went up against during his career. Scholes was quite critical of the Portuguese manager, but Gerrard disagreed.

19 October 2017
Harry and Meghan have tea with the Queen as engagement whispers swirl
According to the Daily Mail , their meeting was kept informal in order to put Meghan more at ease about the important occasion. The Duchess of Cornwall is said to have told a member of staff that Meghan was "a very nice girl and very pleasant".

19 October 2017
FDA Approves Gilead CAR-T Therapy Yescarta, Plans Regenerative Medicine Policy 'Soon'
It was approved in August for B-cell acute lymphoblastic leukemia, the most common form of childhood cancer in the United States. Each treatment is customized using a patient's own immune cells to fight cancer cells.